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ARTICLE
Sensory TRP channels contribute differentially to
skin inﬂammation and persistent itch
Jing Feng1, Pu Yang1, Madison R. Mack2, Dariia Dryn1,3, Jialie Luo1, Xuan Gong1,4, Shenbin Liu1,
Landon K. Oetjen2, Alexander V. Zholos3, Zhinan Mei4, Shijin Yin4, Brian S. Kim2 & Hongzhen Hu1
Although both persistent itch and inﬂammation are commonly associated with allergic
contact dermatitis (ACD), it is not known if they are mediated by shared or distinct signaling
pathways. Here we show that both TRPA1 and TRPV1 channels are required for generating
spontaneous scratching in a mouse model of ACD induced by squaric acid dibutylester
(SADBE), a small molecule hapten, through directly promoting the excitability of pruriceptors.
TRPV1 but not TRPA1 channels protect the skin inﬂammation, as genetic ablation of TRPV1
function or pharmacological ablation of TRPV1-positive sensory nerves promotes cutaneous
inﬂammation in the SADBE-induced ACD. Our results demonstrate that persistent itch and
inﬂammation are mediated by distinct cellular and molecular mechanisms in a mouse model
of ACD. Identiﬁcation of distinct roles of TRPA1 and TRPV1 in regulating itch and inﬂam-
mation may provide new insights into the pathophysiology and treatment of chronic itch and
inﬂammation in ACD patients.
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Contact hypersensitivity (CHS) in allergic contact derma-titis (ACD) is a cutaneous immune response elicited byhapten sensitization, which is primarily mediated by der-
mal dendritic cells (DC) and both CD4+ and CD8+ T cells 1–3.
Squaric acid dibutylester (SADBE), a small molecule hapten, is
commonly used in the treatment of alopecia areata and warts but
often causes CHS4, 5. Consistent with clinical observations,
SADBE can also effectively induce CHS in a mouse model of
ACD in which pre-sensitization and subsequent challenges with
SADBE produce marked epidermal hyperplasia and spontaneous
scratching behaviors, recapitulating symptoms of ACD in
humans6. However, the molecules and cells involved in the
generation of SADBE-induced CHS, especially persistent itch,
remain elusive.
Mammalian transient receptor potential (TRP) channels are a
group of cation channels expressed by numerous animal cells and
play important roles in both health and disease7. Several TRP
channels, especially the TRPA1 and TRPV1 channels, are selec-
tively expressed by a subpopulation of small-diameter primary
sensory neurons and serve as molecular sensors for both innoc-
uous and noxious thermal, mechanical, and chemical cues in our
environment8–12. TRPA1 and TRPV1 are involved in the
pathogenesis of both inﬂammatory and neuropathic pain and also
serve as key downstream signaling molecules for histamine-
independent and histamine-dependent itch, respectively13, 14.
Recent studies have also shown that enhanced excitability of
primary sensory neurons expressing itch-mediating mas-rela-
ted G protein-coupled receptors MRGPRA3 and MRGPRD and
several chemokines and chemokine receptors were correlated
with sensory hypersensitivity in response to pre-sensitization and
subsequent challenges with SADBE in mice6, 15, thereby provid-
ing a cellular mechanism accounting for spontaneous scratching
in this mouse model of ACD. Interestingly, activation of TRPA1
and TRPV1 channels could either promote or suppress skin
inﬂammation in CHS in addition to their roles in pain and itch
signal transduction16. For instance, skin edema was signiﬁcantly
diminished in TRPA1-deﬁcient mice while TRPV1 activation
inhibited the development of inﬂammation in a mouse model of
oxazolone-induced CHS17, 18. Although it is well known that both
TRPA1 and TRPV1 are major players in the generation of pain,
itch, and inﬂammation, it is not clear if these sensory TRP
channels are involved in regulating skin inﬂammation and per-
sistent itch in the SADBE-induced ACD model.
Here we show that SADBE is an activator of both TRPA1 and
TRPV1 by directly interacting with speciﬁc amino acid residues
located at their intracellular protein domains. Both sensory TRP
channels are required for generating the SADBE-induced per-
sistent itch. On the other hand, the TRPV1 channels exert a
protective role in suppressing SADBE-induced ear edema
through modulating the function of dermal macrophages. Our
results suggest that chronic skin inﬂammation and persistent itch
in the SADBE-induced CHS are mediated by distinct molecular
mechanisms that rely on the functions of sensory TRP channels.
Results
Lmphocytes contribute to skin inﬂammation but not itch.
Hapten-induced CHS in ACD is commonly accepted as a result
from activated adaptive immune response19. Although the exact
mechanism is not fully understood, conventional protocols
comprising pre-sensitization and subsequent elicitation of deﬁned
skin areas with SADBE are frequently used for the treatment of
alopecia areata and warts. In the pre-sensitization phase, naive
T cells are activated by antigen-presenting cells in the draining
Lymph nodes. After exposure to the same hapten in the elicitation
phase, antigen-speciﬁc T cells initiate the inﬂammatory process
resulting in skin inﬂammation19. Since pre-sensitization is critical
to the induction of T cell-mediated immunity in ACD, we
investigated the effect of pre-sensitization on SADBE-induced
inﬂammation and spontaneous scratching. We measured the ear
thickness and spontaneous scratching in wild-type (wt) C57BL/6J
mice pre-treated with either vehicle acetone or SADBE for 3 days
and challenged with SADBE 5 days later as described6 (Fig. 1a).
Although the group receiving SADBE for both pre-sensitization
and subsequent elicitation displayed a much severer inﬂamma-
tory reaction compared with the group pre-treated with acetone
and then challenged with SADBE, the latter group also showed a
signiﬁcantly increased ear thickness when compared with the
group without SADBE challenges (Fig. 1e). These results suggest
that SADBE can evoke both lymphocyte-dependent and
lymphocyte-independent inﬂammatory responses, similar to
those seen in ACD and irritant contact dermatitis (ICD), which is
a nonallergic inﬂammatory reaction20. Interestingly, the mice
pre-treated with either acetone or SADBE developed comparable
spontaneous scratching as long as they were later challenged with
SADBE (Fig. 1i). Therefore, T cell-mediated immunity con-
tributes partly to SADBE-induced skin inﬂammation but not
persistent itch.
To further investigate whether T cells contribute differentially
to SADBE-induced skin inﬂammation and persistent itch, we
measured both skin inﬂammation and spontaneous scratching
produced by SADBE treatment in the recombination activating
gene 1 knockout (Rag1−/−) mice, which lack both mature T cells
and B cells21 (Fig. 1b). Surprisingly, both ear thickness and the
number of spontaneous scratches after SADBE challenges were
not signiﬁcantly different between the wt and Rag1−/− mice
(Fig. 1f, j). Moreover, wt mice treated with FTY720, a sphingosine
1-phosphate (S1P) analog that blocks egression of T cells from
lymph nodes and subsequent generation of primary effector
T cells22, did not affect SADBE-induced skin inﬂammation and
spontaneous scratching (Supplementary Fig. 1). Interestingly, it
was reported that besides T cells and B cells the natural killer
(NK) cells were also required for generating the CHS in ACD
induced by either 2,4-dinitroﬂuorobenzene or oxazolone23. Thus,
we determined the function of NK cells in SADBE-induced ACD
by using antibody-mediated depletion as described23. Consistent
with previous report, NK cell depletion in wt mice didn’t alleviate
SADBE-induced inﬂammation and persistent itch (Fig. 1c, g and
k). Combined, these results suggest that abolition of T cell or NK
cell priming alone is not sufﬁcient to affect SADBE-induced skin
inﬂammation and persistent itch.
To achieve a complete deﬁciency in lymphocytes, we used
antibody-mediated depletion of NK cells in the Rag1−/− mice
(Fig. 1d). Indeed, skin inﬂammation induced by SADBE in the
Rag1−/− mice treated with anti-NK1.1 antibodies was signiﬁ-
cantly reduced compared with mice receiving control IgG
antibodies (Fig. 1h). Surprisingly, the number of SADBE-
induced spontaneous scratches was still not signiﬁcantly different
between the Rag1−/− mice with and without receiving the anti-
NK1.1 antibodies (Fig. 1l), suggesting that the SADBE-induced
spontaneous scratching does not require lymphocyte-mediated
immunity.
TRPV1 and TRPA1 are required for SADBE-induced chronic
itch. The ﬁnding that the persistent itch induced by SADBE
challenges does not rely on adaptive immunity suggests the
involvement of alternative mechanisms. TRP channels, especially
TRPA1 and TRPV1, are critically involved in generating both
acute and chronic itch and often serve as downstream signaling
effectors converging many signaling cascades resulting from
activation of numerous G protein-coupled receptors in the itch
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transduction pathways7, 24. We therefore investigated whether
these two sensory ion channels are involved in SADBE-induced
persistent itch. Since both TRPA1 and TRPV1 are co-expressed
by the TRPV1-expressing primary afferent C-ﬁbers25, 26 which
are essential to itch responses induced by various pruritogens and
chemical irritants12, 27, we ﬁrst tested if pharmacological ablation
of the TRPV1-positive C-ﬁbers with the ultrapotent capsaicin
analog resiniferotoxin (RTX)28 affects the SADBE-induced
spontaneous scratching (Fig. 2a). Strikingly, the number of
spontaneous scratches after the SADBE challenges was markedly
reduced in mice treated with RTX when compared with mice
treated with vehicle only (Fig. 2c), suggesting that the TRPV1-
positive C-ﬁbers are indeed required for generating the SADBE-
induced spontaneous scratching. We next measured the numbers
of spontaneous scratches in the Trpa1−/−, Trpv1−/− and Trpa1
−/−/Trpv1−/− double knockout (dKO) mice to ask if these two
sensory TRP channels are involved in the generation of SADBE-
induced spontaneous scratching (Fig. 2b). Remarkably, the
numbers of spontaneous scratches were substantially reduced in
all three groups compared with their wt controls (Fig. 2d). Fur-
thermore, SADBE-induced persistent itch was signiﬁcantly sup-
pressed by pharmacological inhibition of TRPA1 and/or TRPV1
function with speciﬁc antagonists (Supplementary Fig 2a). Taken
together, these results suggest that both TRPA1 and TRPV1 are
required for generating the SADBE-induced persistent itch.
TRPA1 and TRPV1 mediate SADBE-induced activation of
DRG. There are at least two possibilities for the involvement of
TRPA1 and TRPV1 channels in the generation of SADBE-
induced persistent itch. One possibility is that SADBE could
stimulate release of endogenous pruritogens from resident skin
cells except for lymphocytes, for instance, keratinocytes, mast
cells, or innate immune cells, which subsequently activate the
TRPV1 and/or TRPA1 channels expressed by pruriceptors7, 29.
Alternatively, SADBE could act as a chemical irritant that pene-
trates the compromised skin barrier resulting from repeated
SADBE challenges and directly promotes excitability of the
cutaneous pruriceptors through activating the TRPA1 and/or
TRPV1 channels. We tested this possibility by using live-cell Ca2+
imaging on dissociated mouse DRG neurons. Bath application of
3 mM SADBE could indeed evoke a large intracellular Ca2+
response in about 56.7% of the wt DRG neurons (Fig. 3a and i).
Interestingly, SADBE elicited an intracellular Ca2+ response in
comparable proportions of Trpa1−/− or Trpv1−/− DRG neurons
where allyl isothiocyanate (AITC)- or capsaicin-elicited Ca2+
response was absent, respectively (Fig. 3b, c and i). On the other
hand, SADBE-induced Ca2+ response was completely absent
from the DRG neurons isolated from the Trpa1−/−/Trpv1−/−
dKO mice (Fig. 3d and i). Taken together, these results suggest
that both TRPA1 and TRPV1 are sensitive to SADBE and only
genetic ablation of both TRPA1 and TRPV1 functions is able to
abolish the SADBE-elicited Ca2+ response in DRG neurons by
eliminating the mutual compensatory effect observed in the DRG
neurons isolated from the single Trpa1−/− or Trpv1−/− mice.
To measure the direct effect of SADBE on the excitability of
primary sensory neurons we performed whole-cell patch clamp
recordings on dissociated DRG neurons. Under the current clamp
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Fig. 1 T lymphocytes contribute partly to skin inﬂammation but not persistent itch. a, e, i Schematic experimental protocol in a was used to test the effect of
pretreatment with vehicle (acetone) or SADBE on ear thickness increment (e) and spontaneous scratching (i) induced by subsequent elicitation of SADBE.
Data are presented as mean± SEM. NS, not signiﬁcant. Asterisks indicate statistical signiﬁcance. *p< 0.05, ***p< 0.001, ****p< 0.0001, ANOVA; b, f, j
Pre-sensitization and subsequent elicitation with SADBE (schematic protocol in b) induced comparable ear thickness increment (f) and spontaneous
scratching (j) between wt and Rag1−/− mice. Data are presented as mean± SEM. NS, not signiﬁcant, Student’s t-test; c, g, k Pre-sensitization and
subsequent elicitation with SADBE (schematic protocol in c) elicited comparable ear thickness increment (g) and spontaneous scratching (k) between wt
mice treated with either control mouse IgGs or anti-NK1.1. Data are presented as mean± SEM. NS, not signiﬁcant, Student’s t-test; d, h, l The Rag1−/− mice
received injections of anti-NK1.1 antibodies had signiﬁcantly less ear thickness increment vs. Rag1−/− mice receiving only control mouse IgGs (h) after pre-
sensitization and subsequent elicitation with SADBE (schematic protocol in d) but the spontaneous scratching behaviors were comparable between Rag1
−/− mice receiving anti-NK1.1 and control mouse IgGs (l). Data are presented as mean± SEM. NS, not signiﬁcant. Asterisks indicate statistical signiﬁcance.
**p< 0.01, Student’s t-test
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membrane depolarization and increased the number of action
potential ﬁring in wt DRG neurons which also responded to both
AITC and capsaicin (Fig. 3e and j). Consistent with the
Ca2+ imaging results, SADBE evoked comparable membrane
depolarizing responses in the DRG neurons isolated from the
Trpa1−/−, Trpv1−/− or wt mice (Fig. 3f, g and j). However, no
membrane depolarization was observed in response to SADBE,
AITC or capsaicin in the DRG neurons isolated from the Trpa1
−/−/Trpv1−/− dKO mice (Figs. 3h and j). To further conﬁrm that
TRPA1 and TRPV1 were the only receptors activated by SADBE
in DRG neurons, we used a higher concentration (10 mM) of
SADBE to fully activate DRG neurons. Although 10 mM SADBE
elicited a robust membrane depolarization associated with
spontaneous action potential ﬁrings isolated from wt mice and
blunted the AITC and capsaicin responses in the same DRG
neurons (Supplementary Fig. 3a, 3b and 3e), no membrane
depolarization, action potential ﬁring or Ca2+ inﬂux were evoked
by 10 mM SADBE in DRG neurons isolated from Trpa1
−/−/Trpv1−/− dKO mice in both current clamp recordings and
Ca2+ imaging assays (Supplementary Fig. 3c, 3d, 3f and 3g). These
results suggest that SADBE could directly activate the primary
sensory neurons and TRPA1 and TRPV1 are the indispensable
targets for SADBE in these neurons.
SADBE directly activates recombinant TRPA1 and TRPV1. To
further test the possibility that SABDE directly activates both
TRPA1 and TRPV1 channels we transfected HEK293 cells with
either human TRPA1 or mouse TRPV1 construct and measured
TRP channel activities using live-cell Ca2+ imaging and whole-cell
patch clamp recordings. As predicted, SADBE evoked large
intracellular Ca2+ responses in both TRPA1- and TRPV1-
transfected HEK293 cells (Fig. 4a and b). In marked contrast,
HEK293 cells transfected with mouse TRPV3, rat TRPV4, or
vector control didn’t show detectable intracellular Ca2+ responses
to SADBE (Supplementary Fig. 4). Furthermore, SADBE acti-
vated membrane currents in HEK293 cells transfected with either
TRPA1 or TRPV1 construct but not the vector control under
voltage-clamp conﬁguration (Fig. 4c–f). The effect of SADBE was
concentration-dependent with an EC50 of 1.30 and 7.26 mM for
HEK293 cells transfected with TRPA1 or TRPV1, respectively
(Figs. 4g and h, Supplementary Tables 1 and 2).
We next determined the amino acid residues in TRPA1 protein
that confer SADBE sensitivity by generating both cysteine and
lysine mutants that are known to disrupt activation of TRPA1 by
noxious electrophilic chemical reagents using site-directed
mutagenesis30, 31. The EC50 value for SADBE activation of
TRPA1 had a 5-fold increase in the TRPA1-K710A mutant in
comparison to wild-type TRPA1 (Fig. 4g, Supplementary Table 1).
However, TRPA1-3C (a combination of C621S, C641S, and
C665S) mutant barely displayed any sensitivity to SADBE while
retained signiﬁcantly larger responses to ﬂufenamic acid (FFA), a
non-electrophilic TRPA1 activator (Supplementary Fig. 5), sug-
gesting that SADBE uses the same interaction sites for
electrophiles to activate TRPA1 (Fig. 4g, Supplementary Table 1).
We also made TRPV1 mutants in which the capsaicin interaction
site was disrupted32. Among these mutants, the potency of
SADBE activation of TRPV1 was not signiﬁcantly affected by
substituting TRPV1-R115 and even increased in TRPV1-M548
but the SADBE-elicited current was almost abolished in the
TRPV1-Y512, TRPV1-S513 and TRPV1-T551 mutants (Fig. 4h,
Supplementary Table 2), suggesting that SADBE interacts with
TRPV1 through the same interaction sites for capsaicin activation
of the channel. Combined, our results provide strong evidence
that SADBE is an activator for both TRPV1 and TRPA1 channels.
SADBE elicits a TRPA1-dependent acute scratching behavior.
Given that SADBE is an activator of both TRPA1 and TRPV1, we
asked if subcutaneous application of SADBE could elicit an acute
scratching response similar to that evoked by chloroquine and
histamine. First, we employed the “cheek assay”, which reportedly
distinguished itch and pain behaviors by measuring hind paw
scratching and forelimb wiping, respectively33. When injected
into the cheeks of the wt mice, 30 mM SADBE produced a robust
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Fig. 2 Both TRPA1 and TRPV1 channels are involved in SADBE-induced persistent itch. a Schematic protocol of nociceptor ablation and induction of SADBE-
induced ACD model; (b) Schematic protocol of SADBE-induced ACD model; (c) SADBE-induced spontaneous scratching in wt mice pre-treated with
vehicle or RTX. Data are presented as mean± SEM. Asterisks indicate statistical signiﬁcance. **p< 0.01, Student’s t-test; (d) SADBE-induced spontaneous
scratching in wt, Trpa1−/−, Trpv1−/−, and Trpa1−/−/Trpv1−/− dKO mice. Data are presented as mean± SEM. Asterisks indicate statistical signiﬁcance.
*p< 0.05; **p< 0.01; ****p< 0.0001, ANOVA
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(Fig. 5a). Furthermore, we didn’t observe any paw licking or
ﬂicking behavior within the ﬁrst 10 mins after intraplantar
injections of 30 mM SADBE (Supplementary Fig. 6a). To further
exclude the possibility that SADBE contributes to mechanical and
thermal pain sensitivities, we performed Von Frey and Har-
greaves tests after paw injections of 30 mM SADBE and no sig-
niﬁcant difference was found in paw withdrawal threshold to
mechanical stimuli or paw withdrawal latency to heat stimuli
compared with mice injected with vehicle only (Supplementary
Fig. 6b, c). These results suggest that SADBE acts primarily as an
itch-evoking compound when applied acutely at the given dosage.
We next tested if TRPA1 and/or TRPV1 were involved in acute
scratching in mice subjected to intradermal injections of SADBE.
As expected, SADBE but not vehicle control produced a robust
scratching behavior in wt mice but not in the Trpa1−/−/Trpv1−/−
dKO mice (Fig. 5b), suggesting that TRPA1 and/or TRPV1 are
essential to SADBE-induced acute itch response. Surprisingly,
although the Trpa1−/− mice displayed a signiﬁcantly attenuated
scratching response, which is similar to that observed in the
Trpa1−/−/Trpv1−/− dKO mice, the SADBE-elicited scratching
was not signiﬁcantly reduced in the Trpv1−/− mice (Fig. 5b).
These results suggest that TRPA1 is the predominant itch
receptor mediating the acute scratching response induced by
subcutaneous applications of SADBE, although both TRPA1 and
TRPV1 are involved in generating persistent itch in the SADBE-
induced ACD model.
TRPV1 deﬁciency promotes skin inﬂammation. When acti-
vated, the cutaneous primary sensory nerve endings, especially
the TRPV1-expressing nociceptive C-ﬁbers, mediate both pain
(afferent function) and neurogenic inﬂammation (efferent func-
tion) and may also contribute to allergic inﬂammatory
responses34, 35. Further, previous studies showed that RTX-
mediated ablation of the TRPV1-positive sensory ﬁbers reduces
imiquimod (IMQ)-induced psoriasis-like ear skin inﬂammation
resulting from activation of the IL-23/IL-17 pathway in the der-
mal dendritic cells/γδ T cells28. To investigate if TRPV1-
expressing C-ﬁbers are involved in SADBE-induced ear edema,
we pre-treated the mice with systemic administration of RTX to
ablate the TRPV1-positive sensory nerve endings. Surprisingly,
the ear edema induced by SADBE challenges was profoundly
increased in the RTX-treated mice (Figs 6a and c), suggesting that
the TRPV1-expressing sensory nerve endings play a protective
role in SADBE-induced skin inﬂammation. Therefore, the
TRPV1-expressing sensory ﬁbers can differentially regulate skin
inﬂammation in an etiology-speciﬁc manner.
To clarify if TRPA1 and/or TRPV1 channels mediate this
protective function, we measured SADBE-induced ear edema in
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Fig. 3 Genetic ablation of TRPA1/TRPV1 abolishes SADBE-induced activation of DRG. a–d Representative time-lapse traces show that SADBE-induced a
robust [Ca2+]i response in 56.7% of wt (317/558, a), 40.2% of Trpa1−/− (220/547, b), 59.5% of Trpv1−/− (334/561, c), and 0% of Trpa1−/−/Trpv1−/−
dKO (0/509, d) DRG neurons. n= 5 coverslips for each genotype; e–h Representative traces show that SADBE-induced depolarization of membrane
potential and action potential ﬁring in DRG neurons isolated from wt (e), Trpa1−/− (f), Trpv1−/− (g) and Trpa1−/−/Trpv1−/− dKO (h) mice, n= 5 for each
genotype; (i) Percentages of DRG neurons responding to SADBE, AITC, capsaicin and KCl in neurons isolated from wt, Trpa1−/−, Trpv1−/− and
Trpa1−/−/Trpv1−/− dKO mice in live-cell Ca2+ imaging assays. Data are presented as mean± SEM; (j) Quantiﬁcation of SADBE-induced depolarization of
membrane potentials of DRG neurons isolated from wt, Trpa1−/−, Trpv1−/− and Trpa1−/−/Trpv1−/− dKO mice. Data are presented as mean± SEM. Asterisks
indicate statistical signiﬁcance. ****p< 0.0001, ANOVA
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the Trpa1−/−, Trpv1−/− and Trpa1−/−/Trpv1−/− dKO mice. We
found that SADBE-induced ear edema was signiﬁcantly increased
in the Trpv1−/− and Trpa1−/−/Trpv1−/− dKO mice but not the
Trpa1−/− mice compared with that in the wt mice (Figs. 6b and
d). Consistent with the result from genetic ablation approach,
pharmacological inhibition of TRPV1 function using a speciﬁc
TRPV1 antagonist AMG517 also aggravated the SADBE-induced
skin inﬂammation (Supplementary Fig. 2b). On the other hand,
SADBE-induced skin inﬂammation was not affected by admin-
istration of a selective TRPA1 channel blocker A 96707936,
further supporting that TRPV1 but not TRPA1 plays a critical
role in modulating ear edema in the SADBE-induced ACD
model.
Inﬂammation is a complex process involving various types
of immune cells and signaling molecules. Both Th1 and Th2 cells
are shown to be important effector cells playing important r
oles in the initiation and maintenance of ACD. It is possible that
the aggravation of ear edema in the TRPV1 KO mice might
result from enhanced inﬁltration of Th1 and/or Th2 cells in
SADBE-induced ACD in the absence of TRPV1 modulation.
To explore this possibility, we analyzed the changes of the Th1
and Th2 populations in the ear preparations dissociated from the
wt, Trpa1−/−, Trpv1−/− and Trpa1−/−/Trpv1−/− dKO mice
following SADBE challenges by ﬂow cytometry. Indeed, the
numbers of both CD4+ and CD4- T cells were increased in both
Trpv1−/− and Trpa1−/−/Trpv1−/− dKO mice after SADBE
treatments (Supplementary Figs. 7, 8a, 8b and 8d), which is
consistent with cutaneous inﬂammation promoted by applica-
tions of SADBE. However, the percentages of neither CD4
+ and CD4− cells in the CD45+ T cell population nor Th1 and Th2
cells in the CD4+ T cell population were signiﬁcantly increased in
the Trpv1−/− mice when compared with that in the wt mice
(Supplementary Figs. 7, 8a, 8c, 8e, 8g and 8i), suggesting
that T cells were not responsible for the aggravated inﬂammation
in the Trpv1−/− mice.
Besides lymphocytes, myeloid cells also exhibit extensive
plasticity in response to inﬂammatory stimuli. Thus, we next
asked if myeloid cells are involved in the aggravated SADBE-
induced skin inﬂammation in the Trpv1−/− mice. Strikingly, we
found that both the cell number and the percentage of
macrophages but not other myeloid populations including dermal
dendritic cells, neutrophils, and NK cells, were signiﬁcantly
increased in both Trpv1−/− and Trpa1−/−/Trpv1−/− dKO mice
when compared with that in wt control and Trpa1−/− mice
(Figs. 7a, b, c, Supplementary Figs. 7 and 9). These results suggest
that macrophages might play a predominant role in the
exacerbation of SADBE-induced skin inﬂammation caused by
the absence of TRPV1 modulation.
Macrophages secrete many inﬂammatory cytokines upon
exposure to inﬂammatory stimuli. All of these molecules,
together, may increase vascular permeability and recruit many
types of inﬂammatory cells to the sites of inﬂammation. Indeed,
deregulated cytokine secretion from macrophages is implicated in
immune-mediated skin diseases including ACD37, 38. Thus, we
measured expression levels of inﬂammatory cytokines in the ear
preparations treated with SADBE in the wt, Trpa1−/−, Trpv1−/−
and Trpa1−/−/Trpv1−/− dKO mice using Real-Time qRT-PCR
(Quantitative Reverse Transcription PCR). Consistent with the
ﬂow cytometry results, the expression levels of TNFɑ, IL-1β, and
IL-6, which are abundantly expressed by dermal macrophages37,
were signiﬁcantly higher in both Trpv1−/− and Trpa1−/−/Trpv1
−/− dKO but not in the wt and Trpa1−/− ear preparations treated
with SADBE (Fig. 7d–f). In marked contrast, the expression levels
of Th1 cytokine IFN-γ and Th2 cytokines IL-4, IL-5, and IL-31
were not signiﬁcantly different among wt, Trpa1−/−, Trpv1−/− or
Trpa1−/−/Trpv1−/− dKO ear preparations (Supplementary
Fig. 10). Together, these data suggest that TRPV1 deﬁciency,
selectively promotes the expression of TNFɑ, IL-1β, and IL-6 in
dermal macrophages in the SADBE-induced ACD model, leading
to an exaggerated inﬂammatory response.
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Fig. 4 Structural basis of SADBE activation of recombinant TRPA1 and TRPV1. a, b Representative time-lapse traces illustrate SADBE-elicited [Ca2+]i
responses in HEK293 cells transfected with TRPA1 (a) and TRPV1 (b) constructs, which could be also activated by AITC and capsaicin, respectively;
c, d Representative current traces illustrate that SADBE activated large outward (at +100mV) and inward currents (at −100mV) in HEK293 cells
transfected with TRPA1 (c) and TRPV1 (d) constructs, which were also activated by AITC or capsaicin, respectively; e, f Representative I-V curves illustrate
that SADBE-activated outwardly rectifying TRPA1 (e) and TRPV1 (f) currents. Note that the TRPA1-expressing HEK293 cell was activated by AITC and the
TRPV1-expressing cell was activated by capsaicin; g Concentration–response relationships of SADBE in wild-type and mutant TRPA1 channels; h
Concentration–response relationships of SADBE in wild-type and mutant TRPV1 channels
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Discussion
Chronic itch is a common symptom of numerous cutaneous and
systemic diseases with unmet medical needs. A better under-
standing of the molecular and cellular mechanisms underlying
chronic itch is critical to the development of effective and safe
therapeutic strategies to provide relief for this debilitating skin
condition. Our data provided the ﬁrst evidence that both TRPA1
and TRPV1 channels are critical mediators of persistent itch in
the mouse model of SADBE-induced contact dermatitis, which is
independent of the lymphocyte-mediated immunity. On the other
hand, TRPV1 functions as a potent modulator of skin inﬂam-
mation induced by pre-sensitization and repeated SADBE chal-
lenges (Fig. 8). By using live-cell Ca2+ imaging and whole-cell
patch clamp recordings we have shown that SADBE directly
activates both TRPA1 and TRPV1 channels through interactions















































Fig. 6 TRPV1-expressing sensory nerves protect against skin inﬂammation. a Bar charts illustrate ear thickness increment in wt mice pre-treated with either
vehicle or RTX. Data are presented as mean± SEM. Asterisks indicate statistical signiﬁcance. *p< 0.05, Student’s t-test; b Bar charts illustrate ear thickness
increment in wt, Trpa1−/−, Trpv1−/− and Trpa1−/−/Trpv1−/− dKO mice. Data are presented as mean± SEM. Asterisks indicate statistical signiﬁcance. *p<
0.05; **p< 0.01, ANOVA; c Representative H&E staining of ear skin sections from wt mice, pre-treated with vehicle or RTX; Scale bar, 100 µm; d
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Fig. 5 TRPA1 is the primary mediator of SADBE-induced acute itch. a Bar charts illustrate acute itch and pain behaviors in wt mice by cheek injections of
SADBE (30mM). Facial wiping with the forelimb was indicative of a pain response, whereas scratching with the hind paw was considered as an itch
response. Asterisks indicate statistical signiﬁcance. Data are presented as mean± SEM. NS, not signiﬁcant. **p< 0.01, Student’s t-test; b Bar charts
illustrate acute itch responses elicited by intradermal injections of vehicle or SADBE (30mM) in the neck of wt, Trpa1−/−, Trpv1−/− and Trpa1−/−/Trpv1−/−
dKO mice. Data are presented as mean± SEM. NS, not signiﬁcant. Asterisks indicate statistical signiﬁcance. *p< 0.05; **p< 0.01, ANOVA
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activation of TRPA1 and TRPV1 by pungent chemical irritants.
Our ﬁndings suggest that TRPA1 and TRPV1 contribute differ-
entially to the pathogenesis of persistent itch and skin inﬂam-
mation in the SADBE-induced CHS.
Application of SADBE elicited a large intracellular Ca2+
response and activated membrane currents in HEK293 cells
transfected with either TRPA1 or TRPV1 but not vector control,
TRPV3, or TRPV4, suggesting a direct activation of these sensory
channels by SADBE. We further showed that point mutations
disrupting TRPA1 activation by AITC or TRPV1 activation by
vanilloids either abolished or severely attenuated SADBE-
activated TRPA1 or TRPV1 responses in heterologous cells,
providing the molecular basis of SADBE activation of these two
sensory TRP channels. SADBE evoked a robust intracellular Ca2+
response and promoted membrane excitability of freshly isolated
wt DRG neurons, as reﬂected by increased membrane depolar-
ization and action potential ﬁring upon applications of SADBE.
Although the intracellular Ca2+ response, action potential ﬁring,
and membrane depolarization induced by SADBE applications
were completely absent in the DRG neurons from the
Trpa1−/−/Trpv1−/− dKO mice, they persisted in the DRG neu-
rons isolated from single Trpa1−/− or Trpv1−/− mice, presumably













































































































































































Fig. 7 TRPV1 deﬁciency promotes the function of dermal macrophages. a Representative FACS plots of macrophages in the ear preparations isolated from
wt, Trpa1−/−, Trpv1−/−, and Trpa1−/−/Trpv1−/− dKO mice. Macrophages were deﬁned as I-Ab-lo/- F4/80+ CD11b+ CD11c-; b, c Quantiﬁcation of the number
(b) and the percentage (c) of macrophages based on ﬂow cytometry analysis. n= 3. Data are presented as mean± SEM. NS, not signiﬁcant. Asterisks
indicate statistical signiﬁcance. **p< 0.01; ***p< 0.001, ANOVA; d–f Expression of proinﬂammatory cytokines TNFɑ (d), IL-1β (e) and IL-6 (f), in the
SADBE-treated ear preparations of wt, Trpa1−/−, Trpv1−/−, and Trpa1−/−/Trpv1−/− dKO mice. Data are presented as mean± SEM. NS, not
signiﬁcant. Asterisks indicate statistical signiﬁcance. *p< 0.05; **p< 0.01; ***p< 0.001; ****p< 0.0001, ANOVA
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sensory channels. Combined, these results strongly suggest that
SADBE directly activates both TRPA1 and TRPV1 channels.
Persistent itch has been considered as an accompanying irri-
tating symptoms of many types of chronic inﬂammatory skin
disorders including atopic dermatitis (AD), ACD, and psoriasis
and management of itch is generally assumed to overlap with that
for the skin inﬂammation29. Indeed, previous studies have shown
that activation of the sensory TRPA1 channels could promote
skin edema, epidermal hyperplasia, and scratching behavior
through releasing sensory neuropeptides to regulate skin immune
responses in mice treated with oxazolone and urushiol, haptens
known to cause CHS17. Moreover, clinical treatment for skin
inﬂammation could indeed improve chronic itch in a number of
itch-related skin disorders including AD39–41. On the other hand,
chronic itch could be secondary to systemic diseases without skin
inﬂammation or primary skin lesions, such as cholestasis and
chronic renal failure42–44. In addition, when immunological
therapies showed promising results to curb skin inﬂammation
their efﬁcacy to improve chronic itch was clearly lower than that
for the inﬂammation in AD patients45. Furthermore, a rapid
onset of treatment effect on itch was observed as early as within 1
day of starting treatment whereas the improvement for inﬂam-
mation generally developed slowly after treatment with Tofaciti-
nib, a janus kinase inhibitor, in psoriasis patients46. These
observations point to a potential mechanistic difference between
itch and inﬂammation in chronic inﬂammatory skin disorders.
These clinical observations are also consistent with our surprising
ﬁnding that the spontaneous scratching in mice following SADBE
challenges was not affected in mice lacking all lymphocytes that
are required for generating the SADBE-induced skin inﬂamma-
tion. Moreover, SADBE could produce inﬂammation and itch in
the affected skin area in mice when directly applied to the ear
without prior sensitization. Our results strongly suggest that
SADBE produces both allergic and irritant contact dermatitis in
mice. While the skin edema results from lymphocyte-mediated
immune response the persistent itch likely also involves non-
immunological reactions similar to that often seen in the irritant
contact dermatitis20.
Primary sensory nerve ﬁbers are required to elicit a CHS
response and denervation of sensory nerve ﬁbers can completely
abolish CHS responses induced by some haptens47. Previous
studies have also elegantly demonstrated that both MrgprA3- and
MrgprD-positive neurons displayed enhanced excitability6 and
CXCR3/CXCL10 signaling pathway contributed to allergic itch
sensation in the SADBE model15. In this study, we have provided
strong evidence showing that the sensory TRPA1 and TRPV1
channels are both required to produce persistent itch induced by
SADBE challenges. Interestingly, both MrgprA3 and MrgprD are
expressed in the TRPV1-positive DRG neurons which also co-
express TRPA125, 26, 48, 49. Although only a small population
(about 20%) of the MrgprD-expression neurons express TRPV1
and MrgprD is a mediator for both pain and itch sensations, most
of the MrgprA3-expressing DRG neurons are TRPV1-positive
and MrgprA3 is a speciﬁc itch receptor48–51. We speculate that
the TRPA1 and TRPV1 are molecular itch sensors in the
MrgprA3- and potentially also in the MrgprD-positive DRG
neurons and promotes membrane excitability and action poten-
tial ﬁring in these itch-mediating neurons following SADBE
challenges.
Interestingly, although both TRPA1 and TRPV1 mediate per-
sistent itch in the SADBE-induced CHS, TRPA1 but not TRPV1
mediates the acute scratching behavior elicited by intradermal
injection of SADBE. One explanation for the discrepancy of
TRPV1-mediated responses in the acute and chronic settings is
that SADBE might be too weak an activator of TRPV1 to elicit a
TRPV1-dependent acute itch when injected intradermally into
the healthy wt mice. On the other hand, TRPV1 function is
known to be sensitized under inﬂammatory states such as in
SADBE-induced ACD, which could decrease the threshold of
SADBE-induced activation of TRPV1 and produce TRPV1-
dependent spontaneous scratching behavior.
Although TRPA1-deﬁciency was shown to reduce skin
inﬂammation in the oxazolone-induced CHS17, the SADBE-
induced cutaneous inﬂammatory response persisted in the
TRPA1 KO mice, suggesting that TRPA1 is differentially involved
in the pathogenesis of skin inﬂammation elicited by different
haptens. Unexpectedly, we found that TRPV1 deﬁciency could
promote the inﬁltration of macrophages and increase the
expression of TNFɑ, IL-1β, and IL-6, which is consistent with the
observations that TRPV1 deﬁciency or pharmacological ablation
of the TRPV1-positive sensory ﬁbers promoted skin inﬂamma-
tion in the SADBE-induced CHS. These ﬁndings are also con-
sistent with previous studies showing that the primary sensory
neurons are actively engaged in regulating the functions of many
skin resident cells such as dermal dendritic cells and keratinocytes
through releasing bioactive substances including neuropeptides to
produce neurogenic inﬂammation and regulate cutaneous
immunity18, 28, 52.
During the sensitization and challenge phases, there is an
extremely complex interaction among different types of immune
cells, such as antigen-presenting cells including macrophages,
antigen-speciﬁc T lymphocytes, NK cells, and peripheral blood
leukocytes (monocytes and neutrophils). While the importance of
antigen-speciﬁc T cells for the induction of ACD is apparent,
contributions of other immune cells may differ in a hapten-
speciﬁc manner. In this study, we found that dermal macrophages
play a critical role in the exacerbation of the inﬂammation in the
TRPV1-deﬁcient mice as the number of dermal macrophages and
the expression of macrophage-derived cytokines including TNFɑ,
IL-1β, and IL-6 are selectively increased in these animals but not
in wt controls or the TRPA1-deﬁcient mice. These results were
consistent with previous studies that macrophages accumulate
and produce high levels of proinﬂammatory cytokines at the sites
of hapten-induced ACD37. It was reported that the induction of
neuropeptides, such as calcitonin gene-related peptide (CGRP)
and substance P (SP), is tightly correlated with the activity of
sensory neurons53, 54. Although it is still unclear how TRPV1
channels control the function of macrophages in SADBE-induced
inﬂammation, we speculate that CGRP but not SP is the most
likely candidate mediating the SADBE action as previous studies
have shown that CGRP strongly inhibits macrophage function











Fig. 8 Working model for SADBE-induced CHS. SADBE could produce
persistent itch by directly activating TRPV1-expressing primary sensory
neurons that modulates skin inﬂammation through regulating the function
of dermal macrophages. Dash lines represent the classic lymphocytes
mediated-inﬂammation pathway in ACD
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In summary, our studies present evidence that the SADBE-
induced persistent itch involves distinct signaling pathways
separable from that mediating skin inﬂammation. The protective
role of TRPV1 through modulating the immune function of
macrophages in SADBE-induced inﬂammation has further
highlighted functional heterogeneity of interactions between the
primary sensory nerves and the cutaneous immune system
(Fig. 8). Recognizing the distinct roles of TRP channels in the
pathogenesis of skin inﬂammation and chronic itch will help to
develop effective treatment strategies for chronic itch in ACD by
targeting speciﬁc TRP channels. Moreover, extra caution should
be taken to avoid unwanted deleterious side effects when using
TRP channel blockers to treat CHS in ACD because the same
TRP channel, for instance, TRPV1, might play distinct roles in
skin inﬂammation and itch.
Methods
Animals. C57BL/6 J and Rag1−/− mice were obtained from Jackson Laboratories
(Bar Harbor, ME, USA). Trpv1+/+ and congenic Trpv1−/− mice on the C57BL/6 J
background were obtained from Jackson Laboratory (Bar Harbor, ME, USA).
Trpa1+/+ and congenic Trpa1−/− mice on the C57BL/6 J background were
described previously57. Both Trpv1−/− and Trpa1−/− mice were continuously
backcrossed to C57BL/6 J. Trpa1−/−/Trpv1−/− dKO mice were generated by
crossing Trpv1−/− and Trpa1−/− animals. All mice were housed under a 12 h light/
dark cycle with food and water provided ad libitum. All behavioral tests were
videotaped from a side angle, and behavioral assessments were done by observers
blind to the treatments or genotypes of animals. All mice used for behavior tests
were genotyped and allocated to experimental groups or control groups. Body
weight- and gender-matched wt, Trpa1−/−, Trpv1−/− and Trpa1−/−/Trpv1−/− dKO
mice were used at 12-weeks old for all the experiments. Rag1−/− mice were used at
10-weeks old. All experiments were performed in accordance with the guidelines of
the National Institutes of Health and the International Association for the Study of
Pain, and were approved by the Animal Studies Committee at Washington Uni-
versity School of Medicine.
HEK293 cell culture and transfection. HEK293 cells were purchased from ATCC
(ATCC CRL-1573). Cells were tested for mycoplasma contamination before cul-
turing in lab and grown as a monolayer maintained in DMEM (Life Technologies,
Carlsbad, CA, USA), supplemented with 10% FBS (Life Technologies), 100 units/
ml penicillin, and 100 μg/ml streptomycin in a humidiﬁed incubator at 37 °C with
5% CO2. cDNAs for mouse TRPV1 (mTRPV1), individual mTRPV1 mutants,
human TRPA1 (hTRPA1), individual hTRPA1 mutants, mouse TRPV3
(mTRPV3), or rat TRPV4 (rTRPV4) were transiently transfected to HEK293 cells
for at least 24 h using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).
QuikChange II XL Mutagenesis Kit (Agilent Technologies, Inc., Santa Clara, CA,
USA) and DNA sequencing were performed to make all the mutants.
Overnight culture of mouse DRG neurons. Murine DRG were isolated and
cultured using a previous described protocol58. In brief, laminectomies were per-
formed on mice and bilateral DRG were dissected out. After removal of connective
tissues, DRG were digested with 1 mL Ca2+/Mg2+-free Hank’s Balanced Salt
Solution (HBSS) containing 1 μL saturated NaHCO3, 0.35 mg L-cysteine, and 20 U
papain (Worthington Biochemical, Lakewood, NJ, USA) for 10 min in 37 °C water
bath. After centrifugation, the supernatants were further treated with 1 mL
Ca2+/Mg2+-free HBSS containing 3.75 mg collagenase type II (Worthington Bio-
chemical, Lakewood, NJ, USA) and 7.5 mg dispase (Worthington Biochemical) for
15 min. Neurons were gently triturated, pelleted, and then resuspended in
Neurobasal-A culture medium containing 2% B-27 supplement (ThermoFisher
Scientiﬁc, Waltham, MA, USA), 100 U/mL penicillin plus 100 μg/mL streptomycin
(Sigma-Aldrich, St. Louis, MO, USA), 100 ng/mL nerve growth factor (NGF,
Sigma), 20 µg/mL glial cell-derived neurotrophic factor (GDNF, Sigma-Aldrich)
and 10% heat-inactivated FBS (Sigma-Aldrich). After plating, DRG neurons were
kept in a humidiﬁed incubator at 37 °C for at least 24 h.
Live-cell Ca2+ imaging. 4 μM Fura-2 AM (Life Technologies) was used to loading
cultured DRG neurons and TRP channel-expressing HEK293 cells were loaded for
60 min. Before use, Fura-2-loaded cells were washed for at least 3 times with HBSS.
Fluorescence was recorded at 340 nm and 380 nm excitation wavelengths using an
inverted Nikon Ti-E microscope with NIS-Elements imaging software (Nikon
Instruments, Inc., Melville, NY, USA). Fura-2 ratios (F340/F380) reﬂecting changes
in [Ca2+]i upon stimulation were monitored and recorded. Cells were considered
responsive if they demonstrated a change in ﬂuorescence ratio >10% of baseline58.
Electrophysiology. Whole-cell patch clamp recordings were performed at room
temperature (22–24 °C) using an Axon 700B ampliﬁer (Molecular Devices,
Sunnyvale, CA, USA). For transfected cells, GFP-expressing cells were selected by a
microscope equipped with a ﬁlter set for GFP visualization (Nikon Instruments
Inc., Melville, NY, USA)58. For DRG neurons, small diameter neurons were pre-
ferred in recording. Pipettes prepared for whole-cell patch clamp recordings were
pulled from borosilicate glass (BF 150-86-10; Sutter Instrument, Novato, CA, USA)
with a Sutter P-1000 pipette. The intracellular solution contains 140 mM CsCl, 2
mM EGTA, and 10 mM HEPES with pH 7.3. Osmolarity was adjusted to 315
mOsm/l with sucrose. To prevent Ca2+-dependent desensitization of TRPV1
currents, a Ca2+-free extracellular solution was made with 140 mM NaCl, 5 mM
KCl, 0.5 mM EGTA, 1 mMMgCl2, 10 mM glucose, and 10 mM HEPES with pH 7.4
and 340 mOsm/l osmolarity. Holding at 0 mV, voltage ramp from −100 to +100
mV for 500 ms was used to record whole-cell current. Resting membrane potential
was recorded with a gap free protocol for each neuron under the current clamp
mode after stabilization (within 3 min). A neuron was included only if the resting
potential was more negative than −40 mV. For current clamp recordings, the
internal solution contained: 140 mM KCl, 1 mM MgCl2, 3 mM MgATP, 1 mM
EGTA, 10 mM HEPES, 10 mM Sucrose with pH 7.2 and 290–300 mOsm/l osmo-
larity. The external solution contained: 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1
mM MgCl2, 10 mM HEPES, 10 mM Glucose and 20 mM Sucrose, pH adjusted at
7.4 with NaOH. Data were acquired using Clampex 10.4 software (Molecular
Devices). Currents were ﬁltered at 2 kHz and digitized at 10 kHz. Data were ana-
lyzed and plotted using Clampﬁt 10 (Molecular Devices). The
concentration–response curve was ﬁtted with the logistic equation: Y= Ymin +
(Ymax−Ymin)/(1 + 10^[(logEC50−X) × Hill slope]), where Y is the response at a
given concentration, Ymax and Ymin are the maximum and minimum responses,
X is the logarithmic value of the concentration and Hill slope is the slope factor of
the curve. EC50 is the concentration that gives a response halfway between Ymax
and Ymin. All data are presented as mean ± SEM.
Quantitative RT–PCR. Total RNA was extracted from mouse ear tissue using
RNeasy kit (Qiagen, Germantown, MD, USA) according to manufacturer’s
instructions. RNA was treated with DNase I (Invitrogen) and the cDNA was
synthesized in vitro using ThermoScript RT–PCR System kit (Invitrogen). Reac-
tions were carried out in a volume of 20 μl per reaction containing 10 μl SYBR
Green master mix (2×) (Roche, Risch-Rotkreuz, Switzerland), 0.5 μl cDNA, 1.2 μl 5
μM primer mix, and 8.3 μl water using StepOnePlus real-time PCR system
(Applied Biosystems, Foster City, CA, USA). Relative mRNA expression levels of
different target gene compared to GAPDH were calculated using 2-ΔΔCt methods.
Primer sequences used for each gene were selected from pre-validated PrimeTime
qPCR Assays (Integrated DNA Technologies, Coralville, Iowa, USA). Primer
sequences (5′ to 3′) used were:
TNFɑ: CCCTCACACTCAGATCATCTTCT (forward) and
CTCCTCCACTTGGTGGTTTG (reverse);
IL-1β: TGTAATGAAAGACGGCACACC (forward) and
TCTTCTTTGGGTATTGCTTGG (reverse);
IL-6: TCTAATTCATATCTTCAACCAAGAGG (forward) and
TGGTCCTTAGCCACTCCTTC (reverse);
IFN-γ: GATATCTGGAGGAACTGGCAAAA (forward) and
CTTCAAAGAGTCTGAGGTAGAAAGAGATAAT (reverse);
IL-4: AGATGGATGTGCCAAACGTCCTCA (forward) and
AATATGCGAAGCACCTTGGAAGCC (reverse);
IL-5: CTCCAATGCATAGCTGGTGAT (forward) and
GAGATTCCCATGAGCACAGT (reverse);
IL-31: TCCTATACAGCAAAGCAGCAC (forward) and
CCAGAGACCACAGGCAAAG (reverse).
Hematoxylin and eosin staining. Mouse ears were collected and ﬁxed in 4%
Paraformaldehyde in phosphate-buffered saline (PBS), dehydrated in 30% sucrose,
and embedded in OCT. Twelve-micron sections were generated using a Leica
CM1950 cryostat (Leica Biosystems, Buffalo Grove, IL, USA). Hematoxylin and
Eosin (H&E) staining was performed according to standard protocols.
FTY720 treatment and depletion of NK cells. FTY720 (1 mg/kg), an agonist
which results in S1P receptor internalization, or PBS was injected daily intraper-
itoneally starting from day 0 of SADBE sensitization28. Depletion of NK cells was
effectuated by weekly i.p. injection of 25 μg anti-NK1.1 antibody (eBioscience, San
Diego, CA, USA), starting on the day before SADBE sensitization. Control mice
were injected with the appropriate isotype control IgG antibody (eBioscience)23.
Mouse model of ACD. Squaric acid dibutylester (SADBE) (Tokyo Chemical Co.,
Tokyo, Japan) was used to elicit contact hypersensitivity in the mouse as a model of
allergic contact dermatitis in humans. Mice were sensitized by the topical appli-
cation of 20 µl of 0.5% SADBE in acetone to the shaved abdominal skin once a day
for three consecutive days. 5 days later, the SADBE-treated group was challenged
with a topical application of 20 μl of 0.5% SADBE to the right ear once a day for
three consecutive days whereas acetone alone was used as the vehicle control.
3 days later, the scratching behavior with the hind paw was quantiﬁed by recording
the number of incidences of scratching bouts for 60 min.
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Acute itch behavior. For the intradermal injections of SADBE, a 2.3 M stock
solution was made by dissolving SADBE in DMSO with a ratio of 1:1 (volume).
The ﬁnal 30 mM SADBE solution was prepared by 1:77 dilutions in 0.9% saline.
Mice were shaved on the nape of the neck or in the face 2 days before assay. On the
day of experiment, mice were acclimated for 1 h by placing each of them indivi-
dually in the recording chamber followed by intradermal injection of SADBE to the
nape of the neck and/or cheek. Immediately after the injection, mice were video-
taped for 30 min without any person in the recording room. After the recording,
the videotapes were played back and the number of scratching bouts towards the
injection site was counted by an investigator blinded to the treatment.
Nocifensive behavior. Intraplantar injection of SADBE was used to induce
nociceptive responses. Mice were acclimated for 1 h before recording. Immediately
after injection, the licking/lifting behavior was recorded for 10 min and counted by
an investigator blinded to the treatment.
Pharmacological ablation of TRPV1-positive sensory nerves. Resiniferatoxin
(RTX) (Sigma-Aldrich), a capsaicin analog, was injected subcutaneously into the
ﬂank of 4 week-old mice in three escalating (30, 70, and 100 μg/kg) doses on
consecutive days. Control mice were treated with vehicle solution (DMSO in PBS).
Mice were allowed to rest for 6 weeks before behavioral test.
Measurement of ear edema. Ear thickness was measured with an engineer’s
micrometer (Moore and Wright, Shefﬁeld, England) with 0.1 mm accuracy, before
ear challenge with SADBE and 3 days after the last challenge. Data were expressed
as % increase of ear thickness compared to the initial pre-challenge values.
Flow cytometry analysis. Single cell suspensions of ear skin were prepared by
incubating dermal side down in 500 uL 0.25 mg/mL Liberase TL for 90 min at 37 °
C. After ﬁltration through a 100 µm cell strainer, cell suspensions were stained with
ZombieRed viability dye (423109, Biolegend, San Diego, CA, USA) per manu-
facturer’s instructions and then with conjugated antibodies on ice for 30 min.
Stained cells were then washed and ﬁxed with Cytoperm/Cytoﬁx solution (BD
Biosciences, San Jose, CA, USA) and acquired on an LSR Fortessa X-20 SORP.
Data were analyzed using FlowJo software. anti-mouse CD16/32 (2.4G2) was from
BioXCell (West Lebanon, NH, USA) (CUS-HB-197) and used at 1:300 dilution.
anti-T-bet (4B10) (644803), anti-GATA3 (16E10A23) (653813), anti-mouse CD4
(GK1.5) (100449), anti-mouse CD3ε (145-2C11) (100327), anti-mouse CD45 (30-
F11) (103105, 103111), anti-mouse NKp46 (29A1.4) (137617), anti-mouse/human
CD11b (M1/70) (101245), anti-mouse CD11c (N418) (117328), anti-mouse Ly-6G
(1A8) (127639), anti-mouse F4/80 (BM8) (123146), anti-mouse I-Ab (AF6-120.1)
(116419) were from Biolegend and used at 1:300 dilution.
Statistics. All data are presented as mean ± SEM for n independent observations.
Student’s t-test was used to analyze statistical signiﬁcance between two groups.
ANOVA and repeated measures tests were used to test hypotheses about effects in
multiple groups occurring over time. P< 0.05 was considered signiﬁcantly
different.
Data availability. The data that support the ﬁndings of this study are available
within the article and its supplementary information ﬁles and from the corre-
sponding author upon reasonable request.
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